IMPLENIA AGIMPLENIA AGIMPLENIA AG

IMPLENIA AG

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪645.81 M‬CHF
‪140.96 M‬CHF
‪3.60 B‬CHF
‪13.26 M‬
Beta (1Y)
0.66

About IMPLENIA N

CEO
André Wyss
Headquarters
Opfikon
Employees (FY)
‪9.06 K‬
Founded
1872
ISIN
CH0023868554
FIGI
BBG006M6ZDY4
Implenia AG engages in the provision of construction services. It operates through the following segments: Real Estate, Buildings, Civil Engineering, and Specialties. The Real Estate segment includes project development. The Buildings segment comprises the design and execution of new constructions and modernization of existing properties. The Civil Engineering segment involves tunneling, foundation engineering, and regional business. The Specialties segment consists Implenia's niche offers. The company was founded on November 4, 2005 and is headquartered in Opfikon, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of I8T is 34.901 CHF — it has increased by 0.27% in the past 24 hours. Watch IMPLENIA AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange IMPLENIA AG stocks are traded under the ticker I8T.
I8T stock has risen by 2.51% compared to the previous week, the month change is a 4.10% rise, over the last year IMPLENIA AG has showed a 17.13% decrease.
We've gathered analysts' opinions on IMPLENIA AG future price: according to them, I8T price has a max estimate of 41.00 CHF and a min estimate of 32.00 CHF. Watch I8T chart and read a more detailed IMPLENIA AG stock forecast: see what analysts think of IMPLENIA AG and suggest that you do with its stocks.
I8T reached its all-time high on Jun 12, 2023 with the price of 48.013 CHF, and its all-time low was 22.874 CHF and was reached on Mar 4, 2022. View more price dynamics on I8T chart.
See other stocks reaching their highest and lowest prices.
I8T stock is 1.24% volatile and has beta coefficient of 0.66. Track IMPLENIA AG stock price on the chart and check out the list of the most volatile stocks — is IMPLENIA AG there?
Today IMPLENIA AG has the market capitalization of ‪637.27 M‬, it has decreased by 2.46% over the last week.
Yes, you can track IMPLENIA AG financials in yearly and quarterly reports right on TradingView.
IMPLENIA AG is going to release the next earnings report on Aug 21, 2024. Keep track of upcoming events with our Earnings Calendar.
I8T net income for the last quarter is ‪108.76 M‬ CHF, while the quarter before that showed ‪32.20 M‬ CHF of net income which accounts for 237.81% change. Track more IMPLENIA AG financial stats to get the full picture.
Yes, I8T dividends are paid annually. The last dividend per share was 0.60 CHF. As of today, Dividend Yield (TTM)% is 1.71%. Tracking IMPLENIA AG dividends might help you take more informed decisions.
IMPLENIA AG dividend yield was 1.97% in 2023, and payout ratio reached 7.80%. The year before the numbers were 1.05% and 7.04% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 18, 2024, the company has ‪9.06 K‬ employees. See our rating of the largest employees — is IMPLENIA AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMPLENIA AG EBITDA is ‪209.30 M‬ CHF, and current EBITDA margin is 5.82%. See more stats in IMPLENIA AG financial statements.
Like other stocks, I8T shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMPLENIA AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMPLENIA AG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMPLENIA AG stock shows the buy signal. See more of IMPLENIA AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.